The increasing focus on rare disease management, innovative drug development, and personalized medicine is accelerating growth across the orphan drugs market, metabolic disorder therapeutics, and the broader rare disease pharmaceuticals market. Rare diseases often require specialized treatment approaches due to their complex genetic origins, limited patient populations, and challenging...